Related Experiment Videos
Early-onset neonatal group B streptococcal sepsis: intrapartum antibiotic prophylaxis in the clinical setting
C T Gervasio1, B S Mantaring, S Alankar
1Department of Pediatrics, Wayne State University, Detroit, MI, USA.
Insights
Intrapartum antibiotics effectively prevent early-onset Group B streptococcus (GBS) infection in newborns. However, clinical application of GBS prevention guidelines requires improvement for optimal outcomes.
Area of Science:
- Obstetrics and Gynecology
- Neonatal Medicine
- Infectious Disease Prevention
Background:
- Group B streptococcus (GBS) is a leading cause of early-onset neonatal infection.
- Guidelines recommend intrapartum antibiotics for GBS-colonized pregnant women to prevent neonatal transmission.
- Effective implementation of these guidelines in clinical settings is crucial.
Purpose of the Study:
- To assess the clinical utilization of guidelines for intrapartum antibiotic prophylaxis in preventing early-onset GBS infection.
- To identify challenges in the practical application of GBS prevention strategies.
Main Methods:
- Retrospective review of maternal and infant medical records from 1993.
- Analysis of antibiotic administration rates among GBS-colonized women.
- Comparison of GBS infection rates between infants born to GBS-colonized mothers who received antibiotics and those who did not.
Main Results:
- 77.8% of 443 GBS-colonized women received intrapartum antibiotics.
- Four infants born to GBS-colonized mothers who received antibiotics developed GBS infection.
- Infants born to GBS-colonized mothers who did not receive antibiotics had a significantly higher risk of GBS infection (OR 9.0, 95% CI 2.8-29.1).
Conclusions:
- Intrapartum antibiotic prophylaxis is a vital strategy for preventing early-onset neonatal GBS infections.
- Clinical application of GBS prevention guidelines presents challenges that need to be addressed.
- Further optimization of guideline implementation is necessary to maximize the benefits of antibiotic prophylaxis.
Objective:
To evaluate how guidelines for the use of intrapartum antibiotics for the prevention of early-onset Group B streptococcal infection are utilized in a clinical setting.
Study Design:
Review of maternal/infant records for the year 1993 in a perinatal center.
Results:
Intrapartum antibiotics were administered to 77.8% of 443 Group B streptococcus (GBS)-colonized women. There were 452 infants born to these mothers, of which four developed GBS infection. During the same period, an additional 11 infants with GBS infection were born to women with "negative" or "unknown" GBS status (the women did not receive intrapartum antibiotics). Infants of GBS-colonized women who had not receive antibiotics were more likely to develop infection than GBS negative or unknown status, odds ratio 9.0, 95% confidence interval (2.8-29.1).
Conclusion:
This study supports the use of intrapartum antibiotics as an important means of preventing early-onset neonatal GBS infection but demonstrates problems that may be encountered in the clinical application of guidelines for intrapartum antibiotic prophylaxis.